Cardio Diagnostics Holdings Inc. Warrant 2022-25.10.27 on Cardio Dgns Hld
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.9049 USD
−8.38 M USD
34.89 K USD
1.70 M
About Cardio Diagnostics Holdings Inc.
Sector
Industry
CEO
Meeshanthini V. Dogan
Website
Headquarters
Chicago
Founded
2017
ISIN
US14159C1119
FIGI
BBG013P15KL9
Cardio Diagnostics Holdings, Inc. engages in the provision of medical diagnostic testing services. It also develops and commercializes a series of products for major types of cardiovascular disease and associated co-morbidities including coronary heart disease (CHD), stroke, heart failure, and diabetes. The company was founded in 2007, and is headquartered in Chicago, IL.
Displays a symbol's price movements over previous years to identify recurring trends.